REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC) /
The cash flow of REGENCELL BIOSCIENCE HOLDINGS LIMITED over the past 8 years
Chart REGENCELL BIOSCIENCE HOLDINGS LIMITED: operating cash flow, capital expenditures, free cash flow, fiscal 2019–2026 Open the chart →In fiscal 2025, REGENCELL BIOSCIENCE HOLDINGS LIMITED's operating cash flow was -$3.11M and its capital expenditures $152.69K, leaving free cash flow of -$3.27M. Free cash flow was below zero in all 5 years shown. It ranged from -$6.05M in fiscal 2022 to -$844.41K in fiscal 2020. Capital expenditures were highest in fiscal 2022, at $780.88K. No free cash flow figure is on file for fiscal 2021 and 2026.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2026ended Jun 30, 2026 | -$7.7M | — | — |
| 2025ended Jun 30, 2025 | -$3.11M | $152.69K | -$3.27M |
| 2024ended Jun 30, 2024 | -$4M | $5.38K | -$4.01M |
| 2023ended Jun 30, 2023 | -$4.96M | $27.39K | -$4.99M |
| 2022ended Jun 30, 2022 | -$5.27M | $780.88K | -$6.05M |
| 2021ended Jun 30, 2021 | -$767.31K | — | — |
| 2020ended Jun 30, 2020 | -$726.57K | $117.84K | -$844.41K |
| 2019ended Jun 30, 2019 | — | — | — |
Fiscal years as REGENCELL BIOSCIENCE HOLDINGS LIMITED reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on REGENCELL BIOSCIENCE HOLDINGS LIMITED
- The profitability of REGENCELL BIOSCIENCE HOLDINGS LIMITED
- The debt of REGENCELL BIOSCIENCE HOLDINGS LIMITED
- All of REGENCELL BIOSCIENCE HOLDINGS LIMITED's financials, charted
Companies of a similar size
- DIODDIODES INC /DEL/
- MIAXMiami International Holdings, Inc.
- NHCNATIONAL HEALTHCARE CORP
- DORMDorman Products, Inc.
- WDHWaterdrop Inc.
Not investment advice. This page shows what REGENCELL BIOSCIENCE HOLDINGS LIMITED filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.